Pepgen

Description: PepGen uses its EDO platform to develop disease-modifying therapies for genetic diseases, focusing on neuromuscular conditions.

Country: UK

Based in: Oxford

Founded: 2021

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Clinical Trials', 'Medical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.